S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
NASDAQ:ALBT

Avalon GloboCare (ALBT) Stock Price, News & Analysis

$0.31
-0.01 (-2.02%)
(As of 04/19/2024 08:50 PM ET)
Today's Range
$0.30
$0.33
50-Day Range
$0.30
$0.42
52-Week Range
$0.25
$2.42
Volume
22,300 shs
Average Volume
146,400 shs
Market Capitalization
$3.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ALBT stock logo

About Avalon GloboCare Stock (NASDAQ:ALBT)

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing mRNA-based Flash-CAR cell therapy platform. In addition, the company develops Avalon clinical-grade tissue-specific exosome (ACTEX); AVA-Trap, a therapeutic program provides an effective therapeutic option to combat COVID-19 and other life-threatening conditions involving cytokine storms; offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Avalon GloboCare Corp. has strategic partnership with HydroPeptide, LLC to engage in co-development and commercialization of a series of clinical-grade, exosome-based cosmeceutical, and orthopedic products; and corporate research agreement with the University of Pittsburgh of the Commonwealth System of Higher Education. The company was founded in 2016 and is headquartered in Freehold, New Jersey.

ALBT Stock Price History

ALBT Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Avalon Globocare Corp ALBT
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Avalon GloboCare debuts KetoAir app on Apple App Store
News Brief: Avalon GloboCare Corp.
Avalon GloboCare shares surge as recent momentum continues
Stocks in play: Avalon GloboCare Corp.
See More Headlines
Receive ALBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/21/2024
Next Earnings (Estimated)
5/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ALBT
Employees
5
Year Founded
N/A

Profitability

Net Income
$-11,930,000.00
Net Margins
-750.41%
Pretax Margin
-750.41%

Debt

Sales & Book Value

Annual Sales
$1.26 million
Book Value
$0.22 per share

Miscellaneous

Free Float
3,998,000
Market Cap
$3.39 million
Optionable
Not Optionable
Beta
0.19
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. David K. Jin M.D. (Age 56)
    Ph.D., CEO, President & Director
    Comp: $360k
  • Ms. Luisa Ingargiola (Age 57)
    Chief Financial Officer
    Comp: $350k
  • Ms. Meng Li (Age 46)
    COO, Chief Marketing Officer & Secretary
    Comp: $340k

ALBT Stock Analysis - Frequently Asked Questions

How have ALBT shares performed in 2024?

Avalon GloboCare's stock was trading at $0.4830 on January 1st, 2024. Since then, ALBT stock has decreased by 36.7% and is now trading at $0.3055.
View the best growth stocks for 2024 here
.

Are investors shorting Avalon GloboCare?

Avalon GloboCare saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 83,400 shares, a decrease of 29.7% from the March 15th total of 118,600 shares. Based on an average trading volume of 158,100 shares, the days-to-cover ratio is presently 0.5 days. Approximately 1.7% of the company's shares are short sold.
View Avalon GloboCare's Short Interest
.

When is Avalon GloboCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our ALBT earnings forecast
.

When did Avalon GloboCare's stock split?

Shares of Avalon GloboCare reverse split before market open on Tuesday, January 3rd 2023. The 1-10 reverse split was announced on Tuesday, January 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Avalon GloboCare?

Shares of ALBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ALBT) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners